These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 1249680)

  • 1. Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
    Abildgaard CF; Britton M; Harrison J
    J Pediatr; 1976 Feb; 88(2):200-5. PubMed ID: 1249680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
    Kelly P; Penner JA
    JAMA; 1976 Nov; 236(18):2061-4. PubMed ID: 989788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased fibrinopeptide A after prothrombin complex concentrates.
    Viganó S; Cattaneo M; Gervasoni W; Mannucci PM
    Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VII and IX inhibitors.
    Barthels M
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S31-8. PubMed ID: 10499907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
    Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM
    N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of the activated partial thromboplastin time associated with poor venipuncture technic.
    McPhedran P; Clyne LP; Ortoli NA; Gagnon PG; Sanders FJ
    Am J Clin Pathol; 1974 Jul; 62(1):16-20. PubMed ID: 4833734
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: Factor VIII inhibitors.
    Deykin D
    N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
    [No Abstract]   [Full Text] [Related]  

  • 10. Prothrombin complex concentrates. Use in treatment of hemophiliacs with factor VIII inhibitors.
    Yolken RH; Hilgartner MW
    Am J Dis Child; 1978 Mar; 132(3):291-3. PubMed ID: 629247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Longitudinal study of factors X, IX, VIII, V, II and I in the first 6 months of life].
    Duvina PL; Simoni MR; Pezzati M; Poggi G; Rosati C; Trampi F; Duvina G
    Minerva Pediatr; 1987 May; 39(10):421-36. PubMed ID: 3116376
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulation in cephalhaematomas.
    Ströder J; Mingers AM
    Z Kinderheilkd; 1974; 116(4):153-61. PubMed ID: 4825915
    [No Abstract]   [Full Text] [Related]  

  • 14. Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
    Quinlan DJ; Eikelboom JW; Weitz JI
    Circulation; 2013 Sep; 128(11):1179-81. PubMed ID: 23935012
    [No Abstract]   [Full Text] [Related]  

  • 15. A true hypercoagulability state in patients on chronic hemodialysis.
    Erickson RV; Williman M; Pendras JP
    Trans Am Soc Artif Intern Organs; 1966; 12():205-6. PubMed ID: 5960704
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Treatment of hemophilic children who have factor VIII inhibitors.
    Pearson HA
    J Pediatr; 1976 Feb; 88(2):367-8. PubMed ID: 1249715
    [No Abstract]   [Full Text] [Related]  

  • 17. Prothrombin time standardization: Proposal of the standards committee, College of American Pathologists.
    Miale JB; LaFond DJ
    Thromb Diath Haemorrh Suppl; 1968; 35():107-1. PubMed ID: 5761058
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation defects caused by diphenylhydantoin.
    Solomon GE; Hilgartner MW; Kutt H
    Neurology; 1972 Nov; 22(11):1165-71. PubMed ID: 4673559
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood coagulation values of sheep.
    Gajewski J; Povar ML
    Am J Vet Res; 1971 Mar; 32(3):405-9. PubMed ID: 5547008
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of non-activated prothrombin concentrate in the management of haemophilia A with factor VIII antibodies.
    Price DA; d'Souza S; Ekert H
    Aust N Z J Med; 1977 Jun; 7(3):286-90. PubMed ID: 269689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.